More in Industry
Bangladesh’s 5G dilemma: Leap forward or strengthen 4G first?
Nearly seven years ago, in 2018, Bangladesh introduced 4G mobile internet services. Three and a half years later, in late 2021, the country launched 5G services on a trial basis amid grand promises of technological transformation. However, the reality paints a stark contrast: 4G coverage remains inconsistent nationwide, with many remote regions still deprived of […]
BY Shafiqul Islam
Road to data-driven industry: Levels of implementation for creating digital twin
Bangladesh is slowly learning the necessity of data transparency, security, and other measures to create a data-centric society that can ensure good governance. Industries also need to embark on this journey of data automation. Many steel industries, privately owned combined-cycle power plants, a few local home appliance manufacturers, and the pharmaceutical industry are taking such […]
BY Giasuddin M Tauseef
Billions down the drain as state-run data centers falter
Over the past decade, Bangladesh has seen a rise in private investment in data centers, driven by increasing digital demand across sectors like banking, telecom, and education. Several local companies have developed Tier III and Tier IV facilities, offering secure, scalable storage and cloud services. These private centers are well-equipped and strategically located to serve […]
BY Mahmudul Hasan
Behind dairy’s unrealized potential
Not too long ago, the rhythmic clinking of metal milk containers signaled the arrival of the Goalas—traditional milk collectors who supplied fresh dairy to Bangladeshi households. Families would gather around, eager to buy fresh milk delivered straight to their doorsteps. But today, that familiar sight has largely disappeared from urban areas, replaced by neatly packaged […]
BY Md Asaduz Zaman
Why Bangladesh needs stricter pharmaceutical regulations
The pharmaceutical industry operates within a complex and multilayered supply chain involving various hidden intermediaries. How does a medicine reach the patient after being manufactured in a lab (assuming the mandatory clinical trials prior to distribution)? Pharmaceutical manufacturers either distribute their medicine in bulk to a wholesale intermediary or directly form contracts with hospitals and […]
BY Sharmin Jahan Juha